DYFFRYN PHARMACY LIMITEDActive

Company number 04549018Private limited companyIncorporated 2002
⚠ Confirmation statement overdue. It was due on 14 Oct 2026.

Key figures

£115,210-18.8%
Net assets 2024/25
-6.8%
Average annual change 2019/20–2024/25
050 k100 k150 k200 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, DYFFRYN PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand121,149117,43880,40849,44647,794
Total assets279,355275,266241,262210,183343,891
Total liabilities—————
Net assets / total equity175,073170,938162,742141,862115,210
Average number of employees55554

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DYFFRYN PHARMACY LIMITED

Company

DYFFRYN PHARMACY LIMITED is a private limited company registered with Companies House under company number 04549018. It was incorporated on 30 Sep 2002. Its status is active. The registered office is in Ammanford (SA18). Its nature of business (SIC 2007) is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749), other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files abridged accounts (unaudited). Net assets were £115,210, down 18.8% on the previous year. Cash at bank and in hand was £47,794. The company had an average of 4 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 14 Oct 2026.